Literature DB >> 7687219

Expression of c-kit mRNA and protein during the differentiation of human hematopoietic progenitor cells.

Y Yamaguchi1, Y Gunji, M Nakamura, K Hayakawa, M Maeda, H Osawa, K Nagayoshi, T Kasahara, T Suda.   

Abstract

To investigate how c-kit and c-kit ligand play a role in the function of hematopoietic stem cells, we determined the expression of c-kit in sorted human hematopoietic stem cells, CD34+CD33- cells and CD34+CD33+ cells. CD34+ cells constituted approximately 1% of the population of gated bone marrow cells and contained colony-forming cells. Two-color analysis by a fluorescence-activated cell sorter (FACS) revealed that about one-third to one-half of the total CD34+ cell population were positive for the CD33 antigen. To analyze the relative accumulation of c-kit mRNA in sorted cells, we used the reverse transcription-polymerase chain reaction (RT-PCR) method, followed by Southern blot analysis. There was a linear relationship between the amount of input RNA and products amplified in the range of 10(3) to 10(5) cells. Using this procedure, we carried out an analysis of c-kit mRNA expression in CD34+CD33-, CD34+CD33+, CD34-CD33+, and CD34-CD33- cells. Enhanced expression for c-kit mRNA was observed solely in CD34+CD33- cells. In contrast, flow cytometry shows that c-kit protein was expressed most abundantly in CD34+CD33+ cells. Colony-forming cells were generated on a human stromal cell layer for 5 weeks initiated with CD34+CD33- cells but not with CD34+CD33+ cells. During co-culture with stromal cells, CD34+CD33- cells differentiated into CD34+CD33+ cells. From these findings, it is concluded that CD34+CD33+ cells are direct progenies of CD34+CD33- cells. In this differentiation pathway, the expression of c-kit mRNA decreased and the c-kit protein increased.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7687219

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  6 in total

1.  Efficient c-kit receptor-targeted gene transfer to primary human CD34-selected hematopoietic stem cells.

Authors:  Q Zhong; P Oliver; W Huang; D Good; V La Russa; Z Zhang; J R Cork; R W Veith; C Theodossiou; J K Kolls; P Schwarzenberger
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 2.  Molecular characterization of CD34+ human hematopoietic progenitor cells.

Authors:  W Knapp; H Strobl; C Scheinecker; C Bello-Fernandez; O Majdic
Journal:  Ann Hematol       Date:  1995-06       Impact factor: 3.673

3.  The phenotype of freshly isolated and cultured human bone marrow allostimulatory cells: possible heterogeneity in bone marrow dendritic cell populations.

Authors:  W Egner; D N Hart
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

4.  Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.

Authors:  H Nagata; A S Worobec; C K Oh; B A Chowdhury; S Tannenbaum; Y Suzuki; D D Metcalfe
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

5.  Up-regulation of cytokine mRNA in human monocytes and myeloid cell lines by the differentiation/activation factor p48.

Authors:  D P Kestler; S Agarwal; R E Hall
Journal:  Immunology       Date:  1995-11       Impact factor: 7.397

6.  A truncated derivative of FGFR1 kinase cooperates with FLT3 and KIT to transform hematopoietic stem cells in syndromic and de novo AML.

Authors:  Baohuan Cai; Yun Liu; Yating Chong; Stephanie Fay Mori; Atsuko Matsunaga; Hualei Zhang; Xuexiu Fang; Chang-Sheng Chang; John K Cowell; Tianxiang Hu
Journal:  Mol Cancer       Date:  2022-07-29       Impact factor: 41.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.